行情回顾:上周,A 股医药生物指数上涨1.05%,跑输沪深300 指数3.13pp,跑输创业板综指3.47pp,在31 个子行业中排名第29。H 股恒生医疗健康指数上周收涨0.93%,跑赢恒生国企指数0.48pp。上市公司研发进度跟踪:上周,康诺亚的AZD0901 注射液、科伦博泰的HBM9378注射液的临床申请新进承办;恒瑞医药的HRS-7058 胶囊的IND 申请新进承办;恩华药业的...
Source Link行情回顾:上周,A 股医药生物指数上涨1.05%,跑输沪深300 指数3.13pp,跑输创业板综指3.47pp,在31 个子行业中排名第29。H 股恒生医疗健康指数上周收涨0.93%,跑赢恒生国企指数0.48pp。上市公司研发进度跟踪:上周,康诺亚的AZD0901 注射液、科伦博泰的HBM9378注射液的临床申请新进承办;恒瑞医药的HRS-7058 胶囊的IND 申请新进承办;恩华药业的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.